Precision BioSciences, Inc.
DTIL
$4.69
$0.204.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 638.00K | 576.00K | 49.90M | 17.58M | 7.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 638.00K | 576.00K | 49.90M | 17.58M | 7.04M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 638.00K | 576.00K | 49.90M | 17.58M | 7.04M |
| SG&A Expenses | 7.96M | 9.30M | 9.08M | 8.96M | 6.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.48M | 21.85M | 25.75M | 21.77M | 21.93M |
| Operating Income | -24.85M | -21.28M | 24.15M | -4.19M | -14.89M |
| Income Before Tax | -17.75M | -16.43M | 32.75M | 8.59M | -13.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.75M | -16.43M | 32.75M | 8.59M | -13.43M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -2.86M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.75M | -16.43M | 32.75M | 8.59M | -16.29M |
| EBIT | -24.85M | -21.28M | 24.15M | -4.19M | -14.89M |
| EBITDA | -24.39M | -20.56M | 25.24M | -3.04M | -13.61M |
| EPS Basic | -2.22 | -2.25 | 4.70 | 1.70 | -4.06 |
| Normalized Basic EPS | -1.32 | -1.46 | 2.96 | 1.07 | -2.29 |
| EPS Diluted | -2.22 | -2.25 | 4.67 | 1.70 | -4.06 |
| Normalized Diluted EPS | -1.32 | -1.46 | 2.94 | 1.07 | -2.29 |
| Average Basic Shares Outstanding | 8.00M | 7.29M | 6.97M | 5.06M | 3.84M |
| Average Diluted Shares Outstanding | 8.00M | 7.29M | 7.01M | 5.06M | 3.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
